DR. TRIANTAFILLOS JOHN FILLOS M.D. NPI 1598863458

NPI Details

DR. Triantafillos John Fillos, M.D. is a hematology and oncology internal medicine in Bayside, NY with 24 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Triantafillos John Fillos, M.D. NPI is 1598863458. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

4564 FRANCIS LEWIS BLVD STE 202
BAYSIDE, NY
ZIP 11361-085
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1598863458 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Uric acid level, blood (HCPCS:84550)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Iron level (HCPCS:83540)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Phosphate level (HCPCS:84100)
• Magnesium level (HCPCS:83735)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Folic acid level, serum (HCPCS:82746)
• Red blood count, manual test (HCPCS:85044)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Vitamin d-3 level (HCPCS:82306)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of drug or substance into vein (HCPCS:96374)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Drawing of blood for a medical problem (HCPCS:99195)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Rheumatoid factor level (HCPCS:86431)
• Testosterone (hormone) level, total (HCPCS:84403)
• Blood test, clotting time (HCPCS:85610)
• Bilirubin level, total (HCPCS:82247)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Acute hepatitis panel (HCPCS:80074)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Hemoglobin a1c level (HCPCS:83036)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Urinalysis, manual test (HCPCS:81002)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)

The enumeration date for this NPI number is 9/21/2006 and was last updated on 1/17/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: